. | All individuals . | Men . | Women . |
---|---|---|---|
n | 1,422 | 591 | 831 |
White (reference group) | 1.00 (1.00) | 1.00 (1.00) | 1.00 (1.00) |
Black | 0.61 (0.40–0.96)* | 0.70 (0.34–1.42) | 0.52 (0.28–0.96)* |
Hispanic | 0.93 (0.59–1.48) | 1.35 (0.74–2.46) | 0.63 (0.31–1.27) |
. | All individuals . | Men . | Women . |
---|---|---|---|
n | 1,422 | 591 | 831 |
White (reference group) | 1.00 (1.00) | 1.00 (1.00) | 1.00 (1.00) |
Black | 0.61 (0.40–0.96)* | 0.70 (0.34–1.42) | 0.52 (0.28–0.96)* |
Hispanic | 0.93 (0.59–1.48) | 1.35 (0.74–2.46) | 0.63 (0.31–1.27) |
Data are OR (95% CI). Adjusted for age, sex (for all individuals only), education, poverty category, employment, marital status, perceived health status, census region, metropolitan statistical area, comorbidity, activity limitation, and BMI. Comorbid conditions: hypertension, ischemic heart disease, angina, myocardial infarction, other heart disease, emphysema, chronic bronchitis, end-stage renal disease, stroke, asthma, lower-back pain, and cancer.
Significant at P < 0.05.